{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:33:43Z","timestamp":1786984423865,"version":"build-2736575974"},"reference-count":107,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.ando.2007.06.015","type":"journal-article","created":{"date-parts":[[2012,2,23]],"date-time":"2012-02-23T01:50:12Z","timestamp":1329961812000},"page":"241-250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Hormonal replacement therapy (HRT) in\u00a0postmenopause: a\u00a0reappraisal"],"prefix":"10.1016","volume":"68","author":[{"given":"A.","family":"Caufriez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2007.06.015_bib1","first-page":"82","article-title":"Oocyte apoptosis: prevention strategies, and implications for female aging and the menopause","volume":"64","author":"Tilly","year":"2003","journal-title":"Ann. Endocrinol. (Paris)"},{"key":"10.1016\/j.ando.2007.06.015_bib2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/ageing\/29.1.75","article-title":"Reproductive longevity and increased life expectancy","volume":"29","author":"Brody","year":"2000","journal-title":"Age Ageing"},{"key":"10.1016\/j.ando.2007.06.015_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/03014469100001532","article-title":"Menarcheal age for Norwegian women born 1830-1960","volume":"18","author":"Rosenberg","year":"1991","journal-title":"Ann. Hum. Biol."},{"key":"10.1016\/j.ando.2007.06.015_bib4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1089\/154099903766651586","article-title":"Risk factors for hot flashes in midlife women","volume":"12","author":"Whiteman","year":"2003","journal-title":"J. Womens Health (Larchmt)"},{"key":"10.1016\/j.ando.2007.06.015_bib5","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0015-0282(98)00137-X","article-title":"Biochemical, metabolic, and vascular mechanisms in menopausal hot flashes","volume":"70","author":"Freedman","year":"1998","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ando.2007.06.015_bib6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1210\/rp.57.1.257","article-title":"Hormonal changes in the menopause transition","volume":"57","author":"Burger","year":"2002","journal-title":"Recent Prog. Horm. Res."},{"key":"10.1016\/j.ando.2007.06.015_bib7","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0002-9378(12)90817-0","article-title":"Impact of climacteric on well-being. A survey based on 5213 women 39 to 60 years old","volume":"168","author":"Oldenhave","year":"1993","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ando.2007.06.015_bib8","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00042192-200205000-00003","article-title":"A longitudinal study of the treatment of hot flushes: the population study of women in Gothenburg during a quarter of a century","volume":"9","author":"Rodstrom","year":"2002","journal-title":"Menopause"},{"key":"10.1016\/j.ando.2007.06.015_bib9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0140-6736(05)66519-1","article-title":"Treatment of menopausal symptoms: what shall we do now?","volume":"366","author":"Hickey","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2007.06.015_bib10","doi-asserted-by":"crossref","first-page":"447","DOI":"10.7326\/0003-4819-85-4-447","article-title":"Menopause and risk of cardiovascular disease: the Framingham study","volume":"85","author":"Kannel","year":"1976","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ando.2007.06.015_bib11","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0140-6736(96)90075-6","article-title":"Age at menopause as a risk factor for cardiovascular mortality","volume":"347","author":"van der Schouw","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2007.06.015_bib12","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1161\/01.CIR.94.4.727","article-title":"Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function","volume":"94","author":"Venkov","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ando.2007.06.015_bib13","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1161\/01.CIR.94.6.1402","article-title":"Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells","volume":"94","author":"Kim-Schulze","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ando.2007.06.015_bib14","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1006\/bbrc.1997.7085","article-title":"17 beta-estradiol inhibits apoptosis of endothelial cells","volume":"237","author":"Alvarez","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ando.2007.06.015_bib15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00024677-200605010-00005","article-title":"Effects of transdermal estrogen replacement therapy on cardiovascular risk factors","volume":"5","author":"Menon","year":"2006","journal-title":"Treat. Endocrinol."},{"key":"10.1016\/j.ando.2007.06.015_bib16","first-page":"170","article-title":"Metabolic effects of oestrogens: impact of the route of administration","volume":"64","author":"Ho","year":"2003","journal-title":"Ann. Endocrinol. (Paris)"},{"key":"10.1016\/j.ando.2007.06.015_bib17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1210\/endo-122-1-325","article-title":"Differential effects of estrogen and growth hormone on uterine and hepatic insulin-like growth factor I gene expression in the ovariectomized hypophysectomized rat","volume":"122","author":"Murphy","year":"1988","journal-title":"Endocrinology"},{"key":"10.1016\/j.ando.2007.06.015_bib18","first-page":"2250","article-title":"Both oral and transdermal estrogen increase growth hormone release in postmenopausal women: a clinical research center study","volume":"81","author":"Friend","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.06.015_bib19","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1210\/jc.2003-022036","article-title":"The impact of dose and route of estrogen administration on the somatotropic axis in normal women","volume":"88","author":"Lissett","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.06.015_bib20","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1053\/meta.2000.6238","article-title":"Effects of oral and transdermal 17 beta-estradiol with cyclical oral norethindrone acetate on insulin sensitivity, secretion, and elimination in postmenopausal women","volume":"49","author":"Spencer","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.ando.2007.06.015_bib21","first-page":"E630","article-title":"Dose-response characteristics for effects of insulin on production and utilization of glucose in man","volume":"240","author":"Rizza","year":"1981","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ando.2007.06.015_bib22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2265.1992.tb01443.x","article-title":"Impact of octreotide, a long-acting somatostatin analogue, on glucose tolerance and insulin sensitivity in acromegaly","volume":"36","author":"Ho","year":"1992","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ando.2007.06.015_bib23","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(89)92328-3","article-title":"Beneficial effects of growth hormone treatment in GH-deficient adults","volume":"1","author":"Jorgensen","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2007.06.015_bib24","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1210\/jcem-70-4-1179","article-title":"Short-term effects of growth hormone on fuel oxidation and regional substrate metabolism in normal man","volume":"70","author":"Moller","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.06.015_bib25","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM198912283212605","article-title":"The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency","volume":"321","author":"Salomon","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ando.2007.06.015_bib26","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1172\/JCI2773","article-title":"The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women","volume":"102","author":"O'Sullivan","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ando.2007.06.015_bib27","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/jbmr.5650070711","article-title":"Impact of short-term estrogen administration on growth hormone secretion and action: distinct route-dependent effects on connective and bone tissue metabolism","volume":"7","author":"Ho","year":"1992","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ando.2007.06.015_bib28","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0015-0282(01)01699-5","article-title":"Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000","volume":"75","author":"Godsland","year":"2001","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ando.2007.06.015_bib29","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1210\/jcem-73-2-373","article-title":"Changes in plasma lipoprotein and apolipoprotein composition in relation to oral versus percutaneous administration of estrogen alone or in cyclic association with utrogestan in menopausal women","volume":"73","author":"Moorjani","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.06.015_bib30","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1210\/jcem-62-3-536","article-title":"Biological effects of estradiol-17 beta in postmenopausal women: oral versus percutaneous administration","volume":"62","author":"De Lignieres","year":"1986","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.06.015_bib31","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1161\/01.CIR.0000032261.12632.D7","article-title":"Different effects of oral conjugated equine estrogen and transdermal estrogen replacement therapy on size and oxidative susceptibility of low-density lipoprotein particles in postmenopausal women","volume":"106","author":"Wakatsuki","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ando.2007.06.015_bib32","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1161\/01.ATV.10.6.1051","article-title":"Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone","volume":"10","author":"Adams","year":"1990","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.ando.2007.06.015_bib33","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/01.CIR.93.3.577","article-title":"Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery","volume":"93","author":"Chen","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ando.2007.06.015_bib34","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1172\/JCI118307","article-title":"Estrogen inhibits the response-to-injury in a mouse carotid artery model","volume":"96","author":"Sullivan","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ando.2007.06.015_bib35","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0008-6363(01)00466-7","article-title":"Estrogen replacement therapy, atherosclerosis, and vascular function","volume":"53","author":"Mikkola","year":"2002","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ando.2007.06.015_bib36","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00993.2006","article-title":"Medroxyprogesterone Acetate Prevents the Cardioprotective and Antiinflammatory Effects of 17 {beta}-estradiol in an in vivo Model of Myocardial Ischemia-Reperfusion","author":"Booth","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ando.2007.06.015_bib37","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1161\/01.CIR.95.7.1768","article-title":"Estradiol accelerates functional endothelial recovery after arterial injury","volume":"95","author":"Krasinski","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ando.2007.06.015_bib38","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1161\/01.ATV.17.11.3071","article-title":"Effects of oral and transdermal estrogen\/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial","volume":"17","author":"Scarabin","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ando.2007.06.015_bib39","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1055\/s-0037-1615643","article-title":"Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women","volume":"85","author":"Vehkavaara","year":"2001","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ando.2007.06.015_bib40","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1055\/s-0038-1657379","article-title":"Differential AT III-response to oral and parenteral administration of 17 beta-estradiol","volume":"49","author":"Conard","year":"1983","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ando.2007.06.015_bib41","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1055\/s-0038-1649632","article-title":"Haemostatic variables and menopausal status: influence of hormone replacement therapy","volume":"70","author":"Scarabin","year":"1993","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ando.2007.06.015_bib42","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/01.ATV.0000087141.05044.1F","article-title":"Differential effects of oral and transdermal estrogen\/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial","volume":"23","author":"Oger","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ando.2007.06.015_bib43","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0002-9343(02)01209-3","article-title":"Effects of hormone replacement therapy on C-reactive protein levels in healthy postmenopausal women: comparison between oral and transdermal administration of estrogen","volume":"113","author":"Modena","year":"2002","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ando.2007.06.015_bib44","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/00365510601113241","article-title":"High C-reactive protein levels are associated with oral hormonal menopausal therapy but not with intrauterine levonorgestrel and transdermal estradiol","volume":"67","author":"Blumenfeld","year":"2007","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.ando.2007.06.015_bib45","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1161\/01.CIR.0000028463.74880.EA","article-title":"Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women","volume":"106","author":"Decensi","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ando.2007.06.015_bib46","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0960-0760(00)00061-3","article-title":"Progesterone effect on cell growth, ultrastructural aspect and estradiol receptors of normal human breast epithelial (HBE) cells in culture","volume":"73","author":"Malet","year":"2000","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ando.2007.06.015_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.maturitas.2005.05.003","article-title":"New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits","volume":"52","author":"Modena","year":"2005","journal-title":"Maturitas"},{"key":"10.1016\/j.ando.2007.06.015_bib48","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0029-7844(97)00212-3","article-title":"Differences in the estrogen content of breast adipose tissue in women by menopausal status and hormone use","volume":"90","author":"O'Brien","year":"1997","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ando.2007.06.015_bib49","first-page":"8448","article-title":"Abnormal expression of 17 beta-hydroxysteroid dehydrogenases in breast cancer predicts late recurrence","volume":"61","author":"Gunnarsson","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.ando.2007.06.015_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5122(02)00141-X","article-title":"Estradiol metabolism and malignant disease","volume":"43","author":"Mueck","year":"2002","journal-title":"Maturitas"},{"key":"10.1016\/j.ando.2007.06.015_bib51","first-page":"1","article-title":"Smoking, estradiol metabolism and hormone replacement therapy","volume":"53","author":"Mueck","year":"2003","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ando.2007.06.015_bib52","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/sj.bjc.6603527","article-title":"A prospective study of postmenopausal hormone use and ovarian cancer risk","volume":"96","author":"Danforth","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ando.2007.06.015_bib53","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.neuroscience.2005.09.006","article-title":"Effects of ovarian hormones on cognitive function in nonhuman primates","volume":"138","author":"Lacreuse","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.ando.2007.06.015_bib54","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1210\/er.2001-0016","article-title":"Estrogen and cognitive functioning in women","volume":"24","author":"Sherwin","year":"2003","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ando.2007.06.015_bib55","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.neuroscience.2005.07.051","article-title":"Estrogen and cognitive aging in women","volume":"138","author":"Sherwin","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.ando.2007.06.015_bib56","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1161\/01.HYP.0000242482.57186.e8","article-title":"Medroxyprogesterone acetate but not drospirenone ablates the protective function of 17 beta-estradiol in aldosterone salt-treated rats","volume":"48","author":"Arias-Loza","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.ando.2007.06.015_bib57","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1210\/endo-109-1-99","article-title":"Glucocorticoid-like actions of medroxyprogesterone acetate upon MtTW15 rat mammosomatotropic pituitary tumors","volume":"109","author":"Winneker","year":"1981","journal-title":"Endocrinology"},{"key":"10.1016\/j.ando.2007.06.015_bib58","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2165\/00002512-200421130-00004","article-title":"New progestogens: a review of their effects in perimenopausal and postmenopausal women","volume":"21","author":"Sitruk-Ware","year":"2004","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ando.2007.06.015_bib59","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/01.GME.0000097847.95550.E3","article-title":"Chronic treatment with progesterone but not medroxyprogesterone acetate restores the endothelial control of vascular tone in the mesenteric artery of ovariectomized rats","volume":"11","author":"Chataigneau","year":"2004","journal-title":"Menopause"},{"key":"10.1016\/j.ando.2007.06.015_bib60","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/01.gme.0000196593.44335.eb","article-title":"Medroxyprogesterone acetate inhibits the cardioprotective effect of estrogen in experimental ischemia-reperfusion injury","volume":"13","author":"Jeanes","year":"2006","journal-title":"Menopause"},{"key":"10.1016\/j.ando.2007.06.015_bib61","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1749-6632.1995.tb31386.x","article-title":"Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity","volume":"761","author":"Muhn","year":"1995","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ando.2007.06.015_bib62","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0010-7824(96)00195-3","article-title":"The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential","volume":"54","author":"Fuhrmann","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.ando.2007.06.015_bib63","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.steroids.2003.08.008","article-title":"Conception and pharmacodynamic profile of drospirenone","volume":"68","author":"Elger","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.ando.2007.06.015_bib64","first-page":"4276","article-title":"Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function","volume":"59","author":"Lydon","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.ando.2007.06.015_bib65","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0002-9378(12)90837-6","article-title":"Estrogen and progesterone receptor content in breast epithelial cells from healthy women during the menstrual cycle","volume":"168","author":"Soderqvist","year":"1993","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ando.2007.06.015_bib66","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0303-7207(77)90108-3","article-title":"Comparison of the in vitro conversion of estradiol-17 beta to estrone of normal and neoplastic human breast tissue","volume":"6","author":"Pollow","year":"1977","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ando.2007.06.015_bib67","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1210\/jcem-55-3-428","article-title":"Estradiol 17 beta-hydroxysteroid dehydrogenase activity in human breast fibroadenomas","volume":"55","author":"Fournier","year":"1982","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.06.015_bib68","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0015-0282(98)00042-9","article-title":"Estradiol and progesterone regulate the proliferation of human breast epithelial cells","volume":"69","author":"Foidart","year":"1998","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ando.2007.06.015_bib69","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1023\/A:1007081021483","article-title":"Bcl-2, survivin and variant CD44 v7-v10 are downregulated and p53 is upregulated in breast cancer cells by progesterone: inhibition of cell growth and induction of apoptosis","volume":"202","author":"Formby","year":"1999","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ando.2007.06.015_bib70","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10549-006-9276-y","article-title":"Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys","volume":"101","author":"Wood","year":"2007","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ando.2007.06.015_bib71","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ijc.2910450131","article-title":"A possible mechanism for increased breast cell proliferation by progestins through increased reductive 17 beta-hydroxysteroid dehydrogenase activity","volume":"45","author":"Coldham","year":"1990","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ando.2007.06.015_bib72","first-page":"4559","article-title":"Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast","volume":"84","author":"Hofseth","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.06.015_bib73","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.fertnstert.2003.07.041","article-title":"Effects of tibolone and continuous combined hormone therapy on mammographic breast density and breast histochemical markers in postmenopausal women","volume":"81","author":"Valdivia","year":"2004","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ando.2007.06.015_bib74","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1210\/edrv-11-2-386","article-title":"Progesterone as a bone-trophic hormone","volume":"11","author":"Prior","year":"1990","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ando.2007.06.015_bib75","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1210\/er.2006-0050","article-title":"Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system","volume":"28","author":"Schumacher","year":"2007","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ando.2007.06.015_bib76","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/09513590600629258","article-title":"Biochemical markers surrogating on vascular effects of sex steroid hormones","volume":"22","author":"Mueck","year":"2006","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.ando.2007.06.015_bib77","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1210\/jc.2003-031272","article-title":"Tibolone and its metabolites induce antimitogenesis in human coronary artery smooth muscle cells: role of estrogen, progesterone, and androgen receptors","volume":"89","author":"Dubey","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.06.015_bib78","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jacc.2005.09.033","article-title":"Tibolone improves myocardial perfusion in postmenopausal women with ischemic heart disease: an open-label exploratory pilot study","volume":"47","author":"Campisi","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ando.2007.06.015_bib79","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.maturitas.2005.11.004","article-title":"Tibolone and its metabolites inhibit invasion of human mammary carcinoma cells in vitro","volume":"54","author":"Vanhoecke","year":"2006","journal-title":"Maturitas"},{"key":"10.1016\/j.ando.2007.06.015_bib80","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000094917","article-title":"Effects of tibolone on sulfatase pathway of estrogens metabolism and on growth of MCF-7 human breast tumors implanted in ovariectomized nude mice","volume":"63","author":"Desreux","year":"2007","journal-title":"Gynecol. Obstet. Invest."},{"key":"10.1016\/j.ando.2007.06.015_bib81","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1677\/erc.1.01159","article-title":"Phytoestrogens and breast cancer \u2014 promoters or protectors?","volume":"13","author":"Rice","year":"2006","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.ando.2007.06.015_bib82","doi-asserted-by":"crossref","first-page":"1983S","DOI":"10.1093\/jn\/133.6.1983S","article-title":"Phytoestrogen supplement use by women","volume":"133","author":"Kurzer","year":"2003","journal-title":"J. Nutr."},{"key":"10.1016\/j.ando.2007.06.015_bib83","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1089\/jwh.2005.14.634","article-title":"Botanical and dietary supplements for menopausal symptoms: what works, what does not","volume":"14","author":"Geller","year":"2005","journal-title":"J. Womens Health (Larchmt)"},{"key":"10.1016\/j.ando.2007.06.015_bib84","series-title":"Endocrinology. Vol 2","first-page":"1751","article-title":"Osteoporosis","author":"Delmas","year":"2006"},{"key":"10.1016\/j.ando.2007.06.015_bib85","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199712043372301","article-title":"Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women","volume":"337","author":"Delmas","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ando.2007.06.015_bib86","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa062462","article-title":"Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women","volume":"355","author":"Barrett-Connor","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ando.2007.06.015_bib87","doi-asserted-by":"crossref","first-page":"26F","DOI":"10.1016\/S0002-9149(01)02219-6","article-title":"Postmenopausal hormone therapy and the risk of cardiovascular disease: the epidemiologic evidence","volume":"90","author":"Hu","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ando.2007.06.015_bib88","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ando.2007.06.015_bib89","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.289.20.2673","article-title":"Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial","volume":"289","author":"Wassertheil-Smoller","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ando.2007.06.015_bib90","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1001\/jama.288.8.980","article-title":"Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study","volume":"288","author":"Pradhan","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ando.2007.06.015_bib91","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa030808","article-title":"Estrogen plus progestin and the risk of coronary heart disease","volume":"349","author":"Manson","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ando.2007.06.015_bib92","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/progestin Replacement Study (HERS) Research Group","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ando.2007.06.015_bib93","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/jwh.2006.15.35","article-title":"Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation","volume":"15","author":"Grodstein","year":"2006","journal-title":"J. Womens Health (Larchmt)"},{"key":"10.1016\/j.ando.2007.06.015_bib94","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ando.2007.06.015_bib95","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1001\/archinte.166.3.357","article-title":"Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative","volume":"166","author":"Hsia","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ando.2007.06.015_bib96","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa010534","article-title":"A clinical trial of estrogen-replacement therapy after ischemic stroke","volume":"345","author":"Viscoli","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ando.2007.06.015_bib97","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","article-title":"Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study","volume":"115","author":"Canonico","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ando.2007.06.015_bib98","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1161\/CIRCULATIONAHA.106.675405","article-title":"Are some types of hormone therapy safer than others? Lessons from the Estrogen and Thromboembolism Risk study","volume":"115","author":"Rexrode","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ando.2007.06.015_bib99","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(97)08233-0","article-title":"Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer","volume":"350","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2007.06.015_bib100","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14596-5","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2007.06.015_bib101","doi-asserted-by":"crossref","DOI":"10.1007\/s10549-007-9523-x","article-title":"Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study","author":"Fournier","year":"2007","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ando.2007.06.015_bib102","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S0140-6736(07)60534-0","article-title":"Ovarian cancer and hormone replacement therapy in the Million Women Study","volume":"369","author":"Beral","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2007.06.015_bib103","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(05)66455-0","article-title":"Endometrial cancer and hormone-replacement therapy in the Million Women Study","volume":"365","author":"Beral","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2007.06.015_bib104","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1001\/jama.289.20.2663","article-title":"Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial","volume":"289","author":"Rapp","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ando.2007.06.015_bib105","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1001\/jama.289.20.2651","article-title":"Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial","volume":"289","author":"Shumaker","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ando.2007.06.015_bib106","series-title":"Le traitement hormonal de la m\u00e9nopause (THM). Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9","year":"2006"},{"key":"10.1016\/j.ando.2007.06.015_bib107","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1056\/NEJMoa012952","article-title":"Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease","volume":"346","author":"Herrington","year":"2002","journal-title":"N. Engl. J. Med."}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426607001576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426607001576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:42:23Z","timestamp":1757716943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426607001576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":107,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0003426607001576"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2007.06.015","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hormonal replacement therapy (HRT) in\u00a0postmenopause: a\u00a0reappraisal","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2007.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}